Investment Opportunities in Health Insurance Sector
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 15 hours ago
0mins
Should l Buy OSCR?
Source: Fool
- Industry Profitability Potential: The health insurance sector presents long-term investment appeal due to the continuous rise in healthcare spending, which reached $5.3 trillion in the U.S. by 2024, indicating the industry's durability and profitability.
- UnitedHealth Group Performance: As the largest health insurer, UnitedHealth Group reported $448 billion in revenue for 2025, and despite challenges like cyberattacks and rising healthcare costs, its net income has been steadily growing, showcasing its resilience in market leadership.
- Oscar Health's Rapid Growth: Oscar Health added 3.4 million members during the 2026 open enrollment period, up from under 1 million at the end of 2021, indicating strong growth potential in the ACA market, despite a medical loss ratio of 87.4%.
- Optimistic Market Outlook: With the aging U.S. population and advancements in medical technology, healthcare costs are expected to continue rising, prompting investors to focus on companies that can effectively manage costs for long-term profitability.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy OSCR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on OSCR
Wall Street analysts forecast OSCR stock price to rise
8 Analyst Rating
1 Buy
4 Hold
3 Sell
Hold
Current: 14.540
Low
11.00
Averages
15.75
High
25.00
Current: 14.540
Low
11.00
Averages
15.75
High
25.00
About OSCR
Oscar Health, Inc. is a healthcare technology company built around a full stack technology platform. The Company's offerings include its insurance business and +Oscar Platform. Its health plans are offered in the individual market. The individual market primarily consists of policies purchased by individuals and families through health insurance marketplaces, established by the ACA and operated by the federal government, as well as other marketplaces operated by individual states. Individuals and families may also purchase policies in the individual market off-exchange. Employees whose employers have chosen to offer an Individual Coverage Health Reimbursement Arrangement (ICHRA) are also able to purchase its health plans. It offers health plans in the individual market under the five metal plan categories defined by the ACA: Catastrophic, Bronze, Silver, Gold, and Platinum. Through the +Oscar platform, the Company deploys its technology to help others throughout the healthcare system.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Investment Opportunities in Health Insurance Sector
- Industry Profitability Potential: The health insurance sector presents long-term investment appeal due to the continuous rise in healthcare spending, which reached $5.3 trillion in the U.S. by 2024, indicating the industry's durability and profitability.
- UnitedHealth Group Performance: As the largest health insurer, UnitedHealth Group reported $448 billion in revenue for 2025, and despite challenges like cyberattacks and rising healthcare costs, its net income has been steadily growing, showcasing its resilience in market leadership.
- Oscar Health's Rapid Growth: Oscar Health added 3.4 million members during the 2026 open enrollment period, up from under 1 million at the end of 2021, indicating strong growth potential in the ACA market, despite a medical loss ratio of 87.4%.
- Optimistic Market Outlook: With the aging U.S. population and advancements in medical technology, healthcare costs are expected to continue rising, prompting investors to focus on companies that can effectively manage costs for long-term profitability.
See More
Investment Opportunities in Healthcare Stocks
- Market Recovery Potential: Despite healthcare stocks like UnitedHealth Group experiencing a 50% drop from their highs, they are expected to rebound in 2026, reflecting the durable value of the industry and the trend of increasing healthcare expenditures.
- Profitability Analysis: UnitedHealth Group reported $448 billion in revenue for 2025, and although net income fell 41% year-over-year due to cyberattacks and rising medical costs, its price-to-earnings ratio of 23.5 indicates potential for future improvement.
- Innovative Business Model: Oscar Health saw enrollment surge to 3.4 million in 2026, up from under 1 million in 2021, demonstrating that its disruptive business model is gaining traction in the ACA marketplace.
- Industry Spending Trends: U.S. healthcare spending has skyrocketed from $74 billion in 1970 to $5.3 trillion in 2024, and this trend is expected to continue, suggesting that as long as insurance companies manage costs effectively, they can achieve long-term profitability.
See More
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
Oscar Health CEO's Share Purchase Sparks Market Attention
- CEO Share Purchase: Oscar Health's CEO Bertolini purchased nearly 1 million shares at $11.92 each this month, totaling $11.9 million, demonstrating confidence in the company's future and potentially boosting investor trust.
- Stock Price Surge: Following the CEO's purchase announcement, Oscar Health's shares jumped 7% in after-hours trading, indicating a positive market reaction to management's confidence, which may attract more investor interest.
- Optimistic Financial Outlook: Oscar Health expects total revenue to reach between $18.7 billion and $19.0 billion by 2026, with a medical loss ratio projected to drop to 82.4% to 83.4%, reflecting efforts to improve profitability and enhance market competitiveness.
- Divergent Analyst Ratings: Among the 10 analysts covering OSCR stock, 2 rated it as 'Strong Buy', 5 as 'Hold', and 3 as 'Sell' or 'Strong Sell', indicating mixed market sentiment regarding the company's prospects, which could influence investor decisions.
See More
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
Investment Opportunities in Health Insurance Sector
- Industry Profitability Potential: The health insurance sector presents long-term investment appeal due to the continuous rise in healthcare spending, which reached $5.3 trillion in the U.S. by 2024, indicating the industry's durability and profitability.
- UnitedHealth Group Performance: As the largest health insurer, UnitedHealth Group reported $448 billion in revenue for 2025, and despite challenges like cyberattacks and rising healthcare costs, its net income has been steadily growing, showcasing its resilience in market leadership.
- Oscar Health's Rapid Growth: Oscar Health added 3.4 million members during the 2026 open enrollment period, up from under 1 million at the end of 2021, indicating strong growth potential in the ACA market, despite a medical loss ratio of 87.4%.
- Optimistic Market Outlook: With the aging U.S. population and advancements in medical technology, healthcare costs are expected to continue rising, prompting investors to focus on companies that can effectively manage costs for long-term profitability.
See More
Investment Opportunities in Healthcare Stocks
- Market Recovery Potential: Despite healthcare stocks like UnitedHealth Group experiencing a 50% drop from their highs, they are expected to rebound in 2026, reflecting the durable value of the industry and the trend of increasing healthcare expenditures.
- Profitability Analysis: UnitedHealth Group reported $448 billion in revenue for 2025, and although net income fell 41% year-over-year due to cyberattacks and rising medical costs, its price-to-earnings ratio of 23.5 indicates potential for future improvement.
- Innovative Business Model: Oscar Health saw enrollment surge to 3.4 million in 2026, up from under 1 million in 2021, demonstrating that its disruptive business model is gaining traction in the ACA marketplace.
- Industry Spending Trends: U.S. healthcare spending has skyrocketed from $74 billion in 1970 to $5.3 trillion in 2024, and this trend is expected to continue, suggesting that as long as insurance companies manage costs effectively, they can achieve long-term profitability.
See More
Oscar Health Stock Rises for Sixth Consecutive Day
- Medicare Reimbursement Increase: Oscar Health's stock surged 12.88% to close at $14.64 on Wednesday, following the announcement that Medicare Advantage reimbursement rates will rise to 2.48% in 2027 from just 0.09% in January, translating to over $13 billion in additional payments, significantly enhancing its financial outlook.
- Strong Market Performance: The stock's sixth consecutive day of gains reflects investor confidence in Oscar Health's growth potential, particularly in light of the increased reimbursement rates for Medicare plans, which are expected to bolster its competitive position in the market.
- Revenue Growth Target: Oscar Health is targeting a revenue increase of 60% to 62% for 2026, aiming for a range of $18.7 billion to $19 billion, compared to $11.7 billion in 2025, which will provide substantial funding for expansion and innovation initiatives.
- Earnings Report Schedule: The company is set to announce its first-quarter earnings before the market opens on May 6, with a conference call to discuss financial and operational highlights, and investor anticipation surrounding this report may further influence stock price movements.
See More
Oscar Health CEO Boosts Market Confidence with $12M Stock Purchase
- CEO Stock Purchase: Oscar Health's CEO Mark Bertolini purchased nearly $12 million worth of company shares on Wednesday morning, demonstrating strong confidence in the firm by acquiring 1 million shares at $11.92 each, totaling approximately $11.9 million.
- Increased Stake: This transaction increased Bertolini's stake in Oscar Health by 11%, bringing his total to 10.2 million shares, thereby reinforcing his control and trust in the company.
- Stock Price Surge: Following Bertolini's stock purchase, Oscar Health's shares rose about 7% on Tuesday, coinciding with the U.S. government's announcement of a 2.5% increase in reimbursements for Medicare Advantage health plans for 2027, surpassing previous proposals.
- Optimistic Market Outlook: Despite macroeconomic challenges anticipated in 2025, Oscar Health maintains an optimistic outlook, with expectations for significant price discovery in 2026, enhancing market confidence in its long-term growth potential.
See More
Oscar Health CEO's Share Purchase Sparks Market Attention
- CEO Share Purchase: Oscar Health's CEO Bertolini purchased nearly 1 million shares at $11.92 each this month, totaling $11.9 million, demonstrating confidence in the company's future and potentially boosting investor trust.
- Stock Price Surge: Following the CEO's purchase announcement, Oscar Health's shares jumped 7% in after-hours trading, indicating a positive market reaction to management's confidence, which may attract more investor interest.
- Optimistic Financial Outlook: Oscar Health expects total revenue to reach between $18.7 billion and $19.0 billion by 2026, with a medical loss ratio projected to drop to 82.4% to 83.4%, reflecting efforts to improve profitability and enhance market competitiveness.
- Divergent Analyst Ratings: Among the 10 analysts covering OSCR stock, 2 rated it as 'Strong Buy', 5 as 'Hold', and 3 as 'Sell' or 'Strong Sell', indicating mixed market sentiment regarding the company's prospects, which could influence investor decisions.
See More
Oscar Health Stock Down but Growth Potential Remains Strong
- Market Share Growth: Oscar Health's membership surged to 3.4 million in 2026, up from 2 million at the end of 2025, demonstrating strong competitiveness in the individual market despite challenges from reduced subsidies.
- Profitability Outlook: The company anticipates operating income between $250 million and $450 million for 2026, which, while a small margin of its projected $18.7 billion to $19 billion revenue, indicates potential for improved profitability.
- Low Market Valuation: With a current market cap of $3.2 billion, Oscar Health trades at less than 10 times the high end of its 2026 operating earnings guidance, suggesting the stock is undervalued and presents a good opportunity for long-term investors.
- Tech-Driven Competitive Edge: As a technology-forward health insurer, Oscar Health's innovations in customer experience allow it to stand out in a challenging environment, and despite rising healthcare costs, its market share continues to grow.
See More
